Granulocytapheresis in the treatment of severe alcoholic hepatitis: A case series

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 4, 2010, Pages 457-460

  Morris, Judith M ^a   Dickson, Sheila ^a   Neilson, Margaret ^a   Hodgins, Paul ^b   Forrest, Ewan H ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b Otsuka Pharmaceuticals   (United Kingdom)

Author keywords

Alcoholic hepatitis; Granulocytapheresis; Tumour necrosis factor

Indexed keywords

BILIRUBIN; PENTOXIFYLLINE; PREDNISOLONE;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CYTAPHERESIS; DISEASE SEVERITY; GRANULOCYTAPHERESIS; HUMAN; KIDNEY FAILURE; MALE; MULTIPLE ORGAN FAILURE; PATIENT SAFETY; PNEUMONIA; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE; VARICOSIS;

ADRENAL CORTEX HORMONES; ADULT; BLOOD COMPONENT REMOVAL; GRANULOCYTES; HEPATITIS, ALCOHOLIC; HUMANS; LEUKOCYTE COUNT; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77949466402     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328332a360     Document Type: Article

References (26)

1. Rambaldi A, Saconato HH, Christensen E, Thorlund K,Wetterslev J, Gluud C. Systematic review: glucocorticoids for alcoholic hepatitis - a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomised clinical trials. Alim Pharm Ther 2008; 27:1167-1178.
2. McCullough AJ, O'Connor JFB. Alcoholic liver disease: proposed recommendations for the American college of gastroenterology. Am J Gastroenterol 1998; 93:2022-2036.
3. Mathurin P, Abdelnour M, Ramond MJ, Carbonell N, Fartoux L, Serfaty L, et al. Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone. Hepatology 2003; 38:1363-1369.
4. Louvet A, Naveau S, Abdelnour M, Ramond M-J, Diaz E, Fartoux L, et al. The lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology 2007; 45:1348-1354.
5. Morris JM, Forrest EH. Bilirubin response to corticosteroids in severe alcoholic hepatitis. Eur J Gastro Hep 2005; 17:759-762.
6. Tilg H, Jalan R, Kaser A, Davies NA, Offner FA, Hodges SJ, et al. Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis. J Hepatol 2003; 38:419-425.
7. Felver ME, Mezey E, McGuire M, Mitchell MC, Herlong HF, Veech GA, et al. Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 1990; 14:255-259.
8. Bird GLA, Sheron N, Goka J, Alexander GJ,Williams RS. Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann Intern Med 1990; 112:917-920.
9. Spahr L, Giostra E, Frossard JL, Bresson-Hadni S, Rubbia-Brandt L, Hadengue A. Soluble TNF-R1, but not tumor necrosis factor alpha, predicts the 3-month mortality in patients with alcoholic hepatitis. J Hepatol 2004; 41:229-234.
10. Spahr L, Rubbia-Brandt L, Frossard JL, Giostra E, Rougemont AL, Pugin J, et al. Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study. J Hepatol 2002; 37:448-455.
11. Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a doubleblind, placebo-controlled trial. Gastroenterology 2000; 119:1637-1648.
12. Naveau S, Chollet-Martin S, Dharancy S, Mathurin P, Jouet P, Piquet M-A, et al. A double-blind randomised controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology 2004; 39:1390-1397.
13. Boetticher NC, Pene CJ, Kwo P, Abrams GA, Patel T, Aqel B, et al. A randomised double-blinded, placebo controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis. Gastroenterology 2008; 135:1953-1960.
14. Saniabadi AR, Hanai H, Fukunaga K, Sawada K, Shima C, Bjarnson I, Lofberg R. Therapeutic leuocytapheresis for inflammatory bowel disease. Trans Apher Sci 2007; 37:191-200.
15. Kashiwagi N, Sugimura K, Koiwai H,Yamamoto H,Yoshikawa T, Saniabadi AR, et al. Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci 2002; 47:1334-1341.
16. Ramlow W, Emmrich J, Ahrenholz P, Sparmann G, Kashiwagi N, Franz M, et al. In vitro and in vivo evaluation of Adacolumn cytapheresis in healthy subjects. J Clin Apher 2005; 20:72-80.
17. Suzuki Y, Yoshimura N, Saniabadi AR, Saito Y. Selective neutrophil and monocyte adsorptive apheresis as a first line treatment for steroid naive patients with active ulcerative colitis: a prospective uncontrolled study. Dig Dis Sci 2004; 49:565-571.
18. Hanai H,Watanabe F, Saniabadi A. Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis. Am J Gastroenterol 2004; 99:1532-1538.
19. Hanai H, Iida T, Watanabe F, Saniaabdi A. Effects of Adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with ulcerative colitis. World J Gastroenterol 2006; 12:3393-3399.
20. Takeda Y, Shiobara N, Saniabadi AR, Hiraishi K. Adhesion dependent release of hepatocyte growth factor and interleukin-1 receptor antagonist from human blood granulocytes and monocytes: evidence for the involvement of plasma IgG, complement C3 and b2 integrin. Inflamm Res 2004; 53:277-283.
21. Taieb J, Delarche C, Paradis V, Mathurin P, Grenier A, Crestani B, et al. Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitis. J Hepatol 2002; 36:342-348.
22. Mendenhall CL, Roos P, Moritz TE, Roselle GA, Chedid A, Grossman CJ, et al. Human hepatocyte growth factor in alcoholic liver disease: a comparison with change in a-fetoprotein. Alcohol Clin Exp Res 1996; 20:1625-1630.
23. Horie Y, Ishii H, Hibi T. Severe alcoholic hepatitis in Japan: prognosis and therapy. Alcohol Exp Clin Res 2005; 29:(Suppl 12):S251-S258
24. Kumashiro R, Koga Y, Kuwahara R, Ide T, Hino T, Tanaka K, et al. Granulocytapheresis (GCAP) for severe alcoholic hepatitis: a preliminary report. Hepatol Res 2006; 36:229-236.
25. Tsuji Y, Kumashiro R, Ishii K, Arinaga T, Sakamoto Y, Tanabe R, et al. Severe alcoholic hepatitis successfully treated by leukocytapheresis: a case report. Alcohol Clin Exp Res 2003; 27:S28-S34.
26. Forrest EH, Evans CDJ, Stewart S, Phillips M, Oo YH, McAvoy N, et al. Analysis of factors related to mortality in alcoholic hepatitis and the derivation and validation of the Glasgow alcoholic hepatitis score. Gut 2005; 54:1174-1179.